{"id":289702,"date":"2025-11-13T19:49:08","date_gmt":"2025-11-13T19:49:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/289702\/"},"modified":"2025-11-13T19:49:08","modified_gmt":"2025-11-13T19:49:08","slug":"ardt-breaking-ardent-health-inc-revenue-drop-triggers-securities-fraud-investigation-after-stock-plummets-33-investors-urged-to-contact-bfa-law","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/289702\/","title":{"rendered":"ARDT BREAKING: Ardent Health, Inc. Revenue Drop Triggers Securities Fraud Investigation after Stock Plummets 33% &#8212; Investors Urged to Contact BFA Law"},"content":{"rendered":"<p>\nLeading securities law firm Bleichmar Fonti &amp; Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws.<\/p>\n<p>\nIf you invested in Ardent, you are encouraged to obtain additional information by visiting: https:\/\/www.bfalaw.com\/cases\/ardent-health-inc-class-action-investigation.<\/p>\n<p>\nWhy Is Ardent being Investigated for Securities Violations?<\/p>\n<p>\nArdent is a provider of healthcare in mid-sized urban communities across the U.S. The Company operates a network of hospitals, ambulatory facilities, and physician practices. During the relevant period, it appears that Ardent improperly accounted for its accounts receivable and professional liability reserves.<\/p>\n<p>\nWhy Did Ardent\u2019s Stock Drop?<\/p>\n<p>\nOn November 12, 2025, Ardent reported its Q3 2025 financial results. The Company revealed it had completed \u201chindsight evaluations of historical collection trends\u201d that resulted in a $43 million decrease in revenue for the quarter. Ardent also revealed that it increased its professional liability reserves by $54 million because of \u201cadverse prior period claim developments\u201d resulting from a set of claims between 2019 and 2022 \u201cas well as consideration of broader industry trends.\u201d On this news, the price of Ardent stock dropped over 33% during the course of trading on November 13, 2025.<\/p>\n<p>\nClick here for more information: https:\/\/www.bfalaw.com\/cases\/ardent-health-inc-class-action-investigation.<\/p>\n<p>\nWhat Can You Do?<\/p>\n<p>\nIf you invested in Ardent you may have legal options and are encouraged to submit your information to the firm.<\/p>\n<p>\nAll representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.<\/p>\n<p>\nSubmit your information by visiting:<\/p>\n<p class=\"bwalignc\">https:\/\/www.bfalaw.com\/cases\/ardent-health-inc-class-action-investigation<\/p>\n<p>\nOr contact:<br \/>\n<br \/>Ross Shikowitz<br \/>\n<br \/>ross@bfalaw.com<br \/>\n<br \/>212.789.3619<\/p>\n<p>\nWhy Bleichmar Fonti &amp; Auld LLP?<\/p>\n<p>\nBFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named \u201cElite Trial Lawyers\u201d by the National Law Journal, among the top \u201c500 Leading Plaintiff Financial Lawyers\u201d by Lawdragon, \u201cTitans of the Plaintiffs\u2019 Bar\u201d by Law360 and \u201cSuperLawyers\u201d by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.\u2019s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.<\/p>\n<p>\nFor more information about BFA and its attorneys, please visit https:\/\/www.bfalaw.com.<\/p>\n<p class=\"bwalignc\">https:\/\/www.bfalaw.com\/cases\/ardent-health-inc-class-action-investigation<\/p>\n<p>\nAttorney advertising. Past results do not guarantee future outcomes.<\/p>\n<p><img decoding=\"async\" style=\"max-width:425px\" alt=\"\" data-zoomable=\"true\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251113568066r1&amp;sid=frzb2&amp;distro=ftp\"\/><\/p>\n<p id=\"mmgallerylink\">View source version on businesswire.com: https:\/\/www.businesswire.com\/news\/home\/20251113568066\/en\/<\/p>\n","protected":false},"excerpt":{"rendered":"Leading securities law firm Bleichmar Fonti &amp; Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT)&hellip;\n","protected":false},"author":2,"featured_media":60790,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[4,450,451,112,3,452,453],"class_list":{"0":"post-289702","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-breaking-news","8":"tag-breaking-news","9":"tag-breakingnews","10":"tag-headlines","11":"tag-markets","12":"tag-news","13":"tag-top-stories","14":"tag-topstories"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/289702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=289702"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/289702\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/60790"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=289702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=289702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=289702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}